Filings & corporate actions
- 4 NovresultsResults · Q2 FY27 · consolidated and standalone+5.1%NSE
- 21 OctshareholdingShareholding · 30 Sept 2026-1.5%NSE
- 5 AugresultsResults · Q1 FY27 · consolidated and standalone+2.7%NSE
- 21 JulshareholdingShareholding · 30 Jun 2026+0.9%NSE
- 3 JuldividendDividend · ₹0.50 per share+2.0%
- 1 JulshareholdingShareholding · 29 Jun 20260.0%NSE
- 8 MayresultsResults · Q4 FY26 · consolidated-0.5%NSE
- 7 MayresultsResults · Q4 FY26 · standalone-0.5%NSE
- 21 AprshareholdingShareholding · 31 Mar 2026+0.7%NSE
- 12 FebresultsResults · Q3 FY26 · consolidated and standalone+0.8%NSE
- 19 JanshareholdingShareholding · 31 Dec 2025-0.4%NSE
- 16 JanshareholdingShareholding · 14 Jan 2026-0.4%NSE
- 6 JanshareholdingShareholding · 5 Jan 2026-1.6%NSE
Reaction to results · all yearsrose on day 0 in 28 of 79 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q2 FY27 | 4 Nov 2026 | +5.1% | +7.7% | — | 2.2× |
| Q1 FY27 | 5 Aug 2026 | +2.7% | -1.2% | -5.5% | 1.6× |
| Q4 FY26 | 7 May 2026 | -0.5% | +12.5% | +7.1% | 1.8× |
| Q3 FY26 | 12 Feb 2026 | +0.8% | +2.4% | +0.5% | 1.6× |
| Q2 FY26 | 11 Nov 2025 | +5.4% | +6.5% | -1.5% | 6.5× |
| Q1 FY26 | 7 Aug 2025 | -5.7% | 0.0% | +0.1% | 1.2× |
| Q4 FY25 | 8 May 2025 | -1.4% | +1.4% | -1.4% | 2.0× |
| Q3 FY25 | 31 Jan 2025 | +1.6% | +11.2% | -15.3% | 1.1× |
| Q2 FY25 | 30 Oct 2024 | -1.4% | +2.3% | +17.0% | 4.9× |
| Q1 FY25 | 9 Aug 2024 | -0.6% | +1.7% | +11.3% | 2.5× |
| Q4 FY24 | 16 May 2024 | 0.0% | +4.5% | +9.5% | 1.0× |
| Q3 FY24 | 9 Feb 2024 | -2.5% | +6.5% | +2.1% | 0.9× |
| Q2 FY24 | 10 Nov 2023 | +3.3% | +3.3% | +4.9% | 0.6× |
| Q1 FY24 | 11 Aug 2023 | -0.6% | +1.5% | +4.3% | 1.2× |
| Q4 FY23 | 24 May 2023 | -1.3% | +0.9% | -1.7% | 1.9× |
| Q3 FY23 | 15 Feb 2023 | +2.0% | -7.6% | -15.0% | 1.9× |
| Q2 FY23 | 15 Nov 2022 | -0.8% | -1.3% | -7.0% | 2.0× |
| Q1 FY23 | 27 Jul 2022 | -5.1% | -2.9% | -6.1% | 6.0× |
| Q4 FY22 | 29 Apr 2022 | +1.2% | -10.2% | -11.1% | 1.0× |
| Q3 FY22 | 21 Jan 2022 | +3.5% | +0.8% | +6.4% | 3.9× |
| Q2 FY22 | 22 Oct 2021 | -0.8% | +7.6% | +11.1% | 1.5× |
| Q1 FY22 | 23 Jul 2021 | -2.2% | -2.0% | -12.2% | 0.9× |
| Q4 FY21 | 29 Apr 2021 | -3.6% | -3.2% | -1.4% | 2.3× |
| Q3 FY21 | 22 Jan 2021 | -2.8% | -0.6% | -2.1% | 2.8× |
| Q2 FY21 | 23 Oct 2020 | -3.5% | -3.1% | +3.9% | 2.2× |
| Q1 FY21 | 24 Jul 2020 | -3.7% | -0.8% | -5.5% | 0.8× |
| Q4 FY20 | 15 May 2020 | +1.0% | +9.1% | +17.2% | 1.3× |
| Q3 FY20 | 24 Jan 2020 | 0.0% | 0.0% | +6.8% | 2.9× |
| Q2 FY20 | 24 Oct 2019 | -1.4% | +7.6% | +7.9% | 1.9× |
| Q1 FY20 | 26 Jul 2019 | +1.4% | -3.1% | -4.1% | 3.3× |
| Q4 FY19 | 10 May 2019 | +1.5% | -2.0% | -0.2% | 0.9× |
| Q3 FY19 | 28 Jan 2019 | -0.1% | 0.0% | -4.5% | 1.0× |
| Q2 FY19 | 29 Oct 2018 | +2.8% | +1.1% | -3.2% | 1.0× |
| Q1 FY19 | 3 Aug 2018 | -1.6% | -1.9% | +7.1% | 0.5× |
| Q4 FY18 | 15 Jun 2018 | -0.5% | +1.7% | -6.6% | 0.5× |
| Q3 FY18 | 13 Mar 2018 | +0.3% | -3.9% | +3.6% | 1.0× |
| Q2 FY18 | 30 Oct 2017 | +2.1% | +14.8% | +15.6% | 0.7× |
| Q1 FY18 | 31 Jul 2017 | -2.1% | -9.0% | -12.4% | 0.7× |
| Q4 FY17 | 17 May 2017 | -0.5% | -5.9% | +4.2% | 0.8× |
| Q3 FY17 | 30 Jan 2017 | -0.9% | +7.6% | +9.2% | 0.8× |
| Q2 FY17 | 24 Oct 2016 | -3.2% | -4.7% | -11.3% | 1.6× |
| Q1 FY17 | 1 Oct 2016 | +3.3% | +1.2% | -2.6% | 0.6× |
| Q4 FY16 | 27 Apr 2016 | +1.2% | +9.9% | +15.0% | 1.8× |
| Q3 FY16 | 22 Jan 2016 | 0.0% | +0.7% | -2.3% | 1.0× |
| Q2 FY16 | 27 Oct 2015 | 0.0% | +1.5% | +3.2% | 0.5× |
| Q1 FY16 | 28 Jul 2015 | -2.0% | +1.7% | -7.2% | 1.0× |
| Q4 FY15 | 9 May 2015 | +1.5% | +3.7% | +0.2% | 0.4× |
| Q3 FY15 | 23 Jan 2015 | -0.9% | +3.1% | +3.0% | 1.9× |
| Q2 FY15 | 27 Oct 2014 | -2.1% | -6.1% | -4.2% | 1.0× |
| Q1 FY15 | 5 Aug 2014 | +1.1% | +1.7% | +6.2% | 0.9× |
| Q4 FY14 | 30 Apr 2014 | -0.8% | +1.6% | -9.7% | 0.6× |
| Q3 FY14 | 23 Jan 2014 | -5.7% | -3.3% | -1.8% | 1.6× |
| Q2 FY14 | 28 Oct 2013 | -0.6% | +6.2% | +11.8% | 0.7× |
| Q1 FY14 | 30 Jul 2013 | -3.6% | -3.7% | +5.6% | 1.2× |
| Q4 FY13 | 10 May 2013 | 0.0% | +1.4% | -0.1% | 0.3× |
| Q3 FY13 | 25 Jan 2013 | +1.6% | +6.7% | +9.0% | 1.2× |
| Q2 FY13 | 31 Oct 2012 | +2.4% | +11.3% | +10.5% | 2.5× |
| Q1 FY13 | 26 Jul 2012 | -5.4% | -3.9% | -1.0% | 2.0× |
| Q4 FY12 | 4 May 2012 | -1.8% | -6.8% | -10.5% | 0.9× |
| Q3 FY12 | 25 Jan 2012 | -3.4% | -3.3% | +3.5% | 2.6× |
| Q2 FY12 | 20 Oct 2011 | -0.3% | +2.2% | -7.8% | 1.6× |
| Q1 FY12 | 21 Jul 2011 | -2.0% | -1.9% | -12.9% | 6.2× |
| Q4 FY11 | 28 Apr 2011 | -4.0% | -7.0% | -13.5% | 4.3× |
| Q3 FY11 | 20 Jan 2011 | -2.0% | -8.2% | -11.1% | 6.9× |
| Q2 FY11 | 22 Oct 2010 | +0.2% | -7.2% | -8.7% | 1.1× |
| Q1 FY11 | 23 Jul 2010 | -3.1% | -6.5% | +6.2% | 4.8× |
| Q4 FY10 | 29 Apr 2010 | +2.9% | -1.4% | -4.1% | 3.9× |
| Q3 FY10 | 21 Jan 2010 | -3.7% | -8.0% | -8.3% | 2.3× |
| Q2 FY10 | 22 Oct 2009 | +0.6% | -8.4% | -1.0% | 3.2× |
| Q1 FY10 | 23 Jul 2009 | +3.1% | +0.7% | +1.0% | 2.2× |
| Q4 FY09 | 28 Apr 2009 | 0.0% | +7.6% | +26.2% | 4.1× |
| Q3 FY09 | 21 Jan 2009 | +1.1% | -11.0% | -8.0% | 6.6× |
| Q2 FY09 | 16 Oct 2008 | -3.7% | -6.7% | -20.9% | 1.4× |
| Q1 FY09 | 17 Jul 2008 | -6.7% | -2.9% | +5.6% | 7.5× |
| Q4 FY08 | 22 Apr 2008 | +0.8% | -3.0% | -6.3% | 27.2× |
| Q3 FY08 | 17 Jan 2008 | -1.4% | -28.3% | -23.9% | 1.2× |
| Q2 FY08 | 18 Oct 2007 | -1.6% | -2.2% | +25.1% | 2.8× |
| Q1 FY08 | 18 Jul 2007 | +0.1% | -3.0% | -5.7% | 6.5× |
| Q4 FY07 | 19 Apr 2007 | -2.6% | -7.5% | -9.6% | 2.6× |
| Average | -0.6% | -0.4% | -0.4% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q2 FY27
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +8.1% | +8.6% | +17.8% | +19.0% | +17.1% | +16.1% |
| Profit | -44.0% | -3.2% | -7.5% | -7.5% | -6.8% | -9.7% |
Key data
Delivery percentage
Over the last 20 sessions BIOCON settled 46.3% of its traded quantity, which is above average for an NSE equity. Its one-year average is 48.8%, so recent sessions are running 2.5 points lower than usual. The latest session ranks higher than 92% of the 3,629 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +0.21% | +0.10% | +10.32% | -11.66% | -15.42% | -11.37% |
Valuation
Ownership
Quarterly results · consolidated
| Q3 FY26 | Q4 FY26 | Q1 FY27 | Q2 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 4,173.0 | 4,516.6 | 4,336.0 | 4,388.9 |
| YoY chg | +9.2% | +2.3% | +10.0% | +2.2% |
| Net profit (₹ Cr) | (51.8) | 198.6 | 136.8 | 56.7 |
| YoY chg | -163.9% | -56.8% | +53.4% | -57.3% |
| Net margin | -1.2% | 4.4% | 3.2% | 1.3% |
| EPS | 1.07 | 0.79 | 0.87 | 0.25 |
Shareholding over time
By quarter
30 Sept 2026 · promoter 44.68% · public 55.14%- Promoter
- Public and others
- Promoter
- 44.68%
- Public
- 55.14%
- Promoter change
- 0.00 pp
- Filed
- 21 Oct 2026
- FII
- 8.64%
- DII
- 29.30%
- Promoter pledged
- 0.00%
Who the public is
- Mutual funds
- 22.08%
- Insurance
- 5.55%
- FPI
- 8.64%
- Retail ≤ ₹2L
- 5.88%
- HNI > ₹2L
- 4.31%
- NRI
- 0.63%
- Bodies corporate
- 5.23%
- Shareholders
- 3,93,051
+6.61 pp QoQ
-0.82 pp QoQ
+0.50 pp QoQ
+0.04 pp QoQ
-0.11 pp QoQ
+0.01 pp QoQ
-0.92 pp QoQ
+0.1% QoQ
Major holders
As of 30 Sept 2026| Holder | Type | Holding | Shares |
|---|---|---|---|
| KIRAN MAZUMDAR-SHAW | Promoter · Individual | 29.73% | 48.46Cr |
| GLENTEC INTERNATIONAL | Promoter · Corporate | 14.56% | 23.72Cr |
| SBI ESG EXCLUSIONARY STRATEGY FUND | Mutual fund | 9.18% | 14.96Cr |
| ICICI PRUDENTIAL RETIREMENT FUND-PURE EQUITY PLAN | Mutual fund | 4.07% | 6.63Cr |
| SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITED | Corporate | 3.40% | 5.54Cr |
| LICI NEW PENSION PLUS GROWTH FUND | Insurance | 2.62% | 4.27Cr |
| KOTAK LARGE & MIDCAP FUND | Mutual fund | 2.57% | 4.20Cr |
| HDFC MUTUAL FUND - HDFC DIVIDEND YIELD FUND | Mutual fund | 1.07% | 1.74Cr |
| RAVI RASENDRA MAZUMDAR | Promoter · Individual | 0.33% | 53.58L |
| DEV MAZUMDAR | Promoter · Individual | 0.06% | 9.30L |
Every promoter-group member, and each public holder above 1%, as filed.
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2026-27 | 1 | ₹0.50 | ₹0.50 |
| FY2025-26 | 1 | ₹0.50 | ₹0.50 |
| FY2024-25 | 1 | ₹0.50 | ₹0.50 |
| FY2023-24 | 1 | ₹1.50 | ₹1.50 |
| FY2022-23 | 1 | ₹0.50 | ₹0.50 |
| FY2019-20 | 1 | ₹0.50 | ₹0.50 |
| FY2018-19 | 1 | ₹1.00 | ₹0.50 |
| FY2017-18 | 1 | ₹1.00 | ₹0.50 |
| FY2015-16 | 2 | ₹10.00 | ₹1.67 |
| FY2014-15 | 1 | ₹5.00 | ₹0.83 |
| FY2013-14 | 1 | ₹7.50 | ₹1.25 |
| FY2012-13 | 1 | ₹5.00 | ₹0.83 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 3 Jul 2026 | — | ₹0.50 | ₹0.50 |
| 4 Jul 2025 | — | ₹0.50 | ₹0.50 |
| 5 Jul 2024 | — | ₹0.50 | ₹0.50 |
| 7 Jul 2023 | — | ₹1.50 | ₹1.50 |
| 30 Jun 2022 | — | ₹0.50 | ₹0.50 |
| 18 Jul 2019 | — | ₹0.50 | ₹0.50 |
| 19 Jul 2018 | — | ₹1.00 | ₹0.50 |
| 20 Jul 2017 | — | ₹1.00 | ₹0.50 |
| 17 Mar 2016 | — | ₹5.00 | ₹0.83 |
| 9 Apr 2015 | — | ₹5.00 | ₹0.83 |
| 10 Jul 2014 | — | ₹5.00 | ₹0.83 |
| 11 Jul 2013 | — | ₹7.50 | ₹1.25 |
| 5 Jul 2012 | — | ₹5.00 | ₹0.83 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
Price-band hits
Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.
Insider trades
- Insiders net, 30d
- ₹0
- Insiders net, 90d
- ₹0
- Promoters net, 90d
- ₹0
- Insider buyers, 90d
- 0
- Last promoter buy
- 6.1 years ago
- Disclosures on record
- 1,434
| Broadcast | Person | Side | Shares | Value | Price | Holding before → after | Stake | Regulation |
|---|---|---|---|---|---|---|---|---|
| 2 Apr 2024 | KIRAN KUMAR GANDHIRAJANEmployee | Sell | 20.0K | ₹52.9L | 264.34 | 1.59L → 1.39L | 0.01%-0.00 pp | 7(2)told 31 Mar 2024 |
| 2 Apr 2024 | Akhilesh NandEmployee | Sell | 11.0K | ₹28.7L | 260.55 | 1.91L → 1.80L | 0.01%-0.00 pp | 7(2)told 30 Mar 2024 |
| 5 Mar 2024 | MANEESH H GHILDYALEmployee | Sell | 5.0K | ₹14.2L | 283.00 | 90.0K → 85.0K | 0.01%-0.00 pp | 7(2)told 4 Mar 2024 |
| 5 Mar 2024 | MANEESH H GHILDYALEmployee | Sell | 1.0K | ₹2.8L | 275.80 | 91.0K → 90.0K | 0.01%-0.00 pp | 7(2)told 4 Mar 2024 |
| 5 Mar 2024 | MANEESH H GHILDYALEmployee | Sell | 2.0K | ₹5.4L | 270.95 | 93.0K → 91.0K | 0.01%-0.00 pp | 7(2)told 4 Mar 2024 |
| 29 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 2.0K | ₹5.6L | 279.20 | 95.0K → 93.0K | 0.01%-0.00 pp | 7(2)told 29 Feb 2024 |
| 29 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 1.0K | ₹2.8L | 277.50 | 98.0K → 97.0K | 0.01%-0.00 pp | 7(2)told 29 Feb 2024 |
| 29 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 1.0K | ₹2.8L | 277.35 | 96.0K → 95.0K | 0.01%-0.00 pp | 7(2)told 29 Feb 2024 |
| 29 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 1.0K | ₹2.8L | 278.55 | 97.0K → 96.0K | 0.01%-0.00 pp | 7(2)told 29 Feb 2024 |
| 27 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 2.0K | ₹5.4L | 270.45 | 1.00L → 98.0K | 0.01%-0.00 pp | 7(2)told 27 Feb 2024 |
| 27 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 5.0K | ₹13.6L | 272.50 | 1.05L → 1.00L | 0.01%-0.00 pp | 7(2)told 27 Feb 2024 |
| 26 Feb 2024 | Gayatri NayakEmployee | Sell | 5.0K | ₹13.6L | 271.50 | 26.5K → 21.5K | 0.00%0.00 pp | 7(2)told 23 Feb 2024 |
| 22 Feb 2024 | MUKESH KAMATH KEmployee | Sell | 5.7K | ₹15.5L | 270.08 | 85.7K → 80.0K | 0.01%-0.00 pp | 7(2)told 22 Feb 2024 |
| 22 Feb 2024 | MUKESH KAMATH KEmployee | Sell | 1.0K | ₹2.9L | 285.00 | 86.7K → 85.7K | 0.01%-0.00 pp | 7(2)told 22 Feb 2024 |
| 22 Feb 2024 | MUKESH KAMATH KEmployee | Sell | 5.0K | ₹14.9L | 298.80 | 91.7K → 86.7K | 0.01%-0.00 pp | 7(2)told 20 Feb 2024 |
| 22 Feb 2024 | KIRAN KUMAR GANDHIRAJANEmployee | Sell | 5.4K | ₹16.3L | 301.50 | 1.64L → 1.59L | 0.01%-0.00 pp | 7(2)told 20 Feb 2024 |
| 22 Feb 2024 | KIRAN KUMAR GANDHIRAJANEmployee | Sell | 5.4K | ₹15.6L | 289.80 | 1.70L → 1.64L | 0.01%-0.00 pp | 7(2)told 20 Feb 2024 |
| 22 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 1.0K | ₹2.8L | 282.09 | 1.06L → 1.05L | 0.01%-0.00 pp | 7(2)told 20 Feb 2024 |
| 22 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 1.0K | ₹2.8L | 282.00 | 1.07L → 1.06L | 0.01%-0.00 pp | 7(2)told 20 Feb 2024 |
| 22 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 1.0K | ₹2.8L | 279.00 | 1.08L → 1.07L | 0.01%-0.00 pp | 7(2)told 20 Feb 2024 |
| 22 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 1.0K | ₹2.8L | 277.00 | 1.09L → 1.08L | 0.01%-0.00 pp | 7(2)told 20 Feb 2024 |
| 16 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 1.0K | ₹2.7L | 271.05 | 1.10L → 1.09L | 0.01%-0.00 pp | 7(2)told 15 Feb 2024 |
| 16 Feb 2024 | MANEESH H GHILDYALEmployee | Sell | 3.0K | ₹8.1L | 269.18 | 1.13L → 1.10L | 0.01%-0.00 pp | 7(2)told 15 Feb 2024 |
| 3 Jan 2024 | SARAVANAN KRISHNANEmployee | Sell | 5.9K | ₹14.8L | 249.60 | 5.9K → — | 0.00% | 7(2)told 3 Jan 2024 |
| 28 Dec 2023 | MANEESH H GHILDYALEmployee | Sell | 3.0K | ₹7.6L | 254.75 | 1.16L → 1.13L | 0.01%-0.00 pp | 7(2)told 28 Dec 2023 |
| 28 Dec 2023 | MANEESH H GHILDYALEmployee | Sell | 2.0K | ₹5.0L | 249.68 | 1.18L → 1.16L | 0.01%-0.00 pp | 7(2)told 28 Dec 2023 |
| 28 Dec 2023 | MANEESH H GHILDYALEmployee | Sell | 2.0K | ₹4.9L | 246.25 | 1.20L → 1.18L | 0.01%-0.00 pp | 7(2)told 28 Dec 2023 |
| 27 Dec 2023 | ARSHAD JAMILOther | Sell | 5.0K | ₹12.6L | 251.00 | 32.8K → 27.8K | 0.00%0.00 pp | 7(2)told 26 Dec 2023 |
| 22 Dec 2023 | KRISHNASAI TANNEERUOther | Sell | 6.0K | ₹15.3L | 255.00 | 32.5K → 26.5K | 0.00%0.00 pp | 7(2)told 21 Dec 2023 |
| 15 Dec 2023 | ARSHAD JAMILOther | Sell | 15.0K | ₹36.7L | 244.67 | 47.8K → 32.8K | 0.00%0.00 pp | 7(2)told 13 Dec 2023 |
| 7 Dec 2023 | VIJAY WAMAN GHOGAREOther | Sell | 8.2K | ₹19.0L | 232.56 | 8.2K → — | 0.00% | 7(2)told 5 Dec 2023 |
| 7 Dec 2023 | SAURABH NARAINEmployee | Sell | 10.0K | ₹23.5L | 234.77 | 33.2K → 23.2K | 0.00%0.00 pp | 7(2)told 6 Dec 2023 |
| 3 Oct 2023 | ANUJ GOELOther | Sell | 30.0K | ₹81.4L | 271.21 | 4.71L → 4.41L | 0.04%-0.00 pp | 7(2)told 30 Sept 2023 |
| 3 Oct 2023 | ANUJ GOELOther | Sell | 20.0K | ₹53.3L | 266.69 | 4.91L → 4.71L | 0.04%-0.00 pp | 7(2)told 30 Sept 2023 |
| 28 Sept 2023 | ABHIJIT ZUTSHIEmployee | Sell | 10.0K | ₹27.0L | 269.70 | 1.08L → 98.4K | 0.01%-0.00 pp | 7(2)told 28 Sept 2023 |
| 20 Sept 2023 | Atanu RoyOther | Sell | 11.8K | ₹31.9L | 269.00 | 11.8K → — | 0.00% | 7(3)told 19 Sept 2023 |
| 5 Sept 2023 | VIRUPAX TOPANNAWAROther | Sell | 15.0K | ₹39.2L | 261.50 | 18.3K → 3.3K | 0.00%0.00 pp | 7(2)told 5 Sept 2023 |
| 5 Sept 2023 | SIVANANDAM KOther | Sell | 27.6K | ₹72.0L | 261.13 | 34.9K → 7.3K | 0.00%0.00 pp | 7(2)told 4 Sept 2023 |
| 30 Aug 2023 | ARSHAD JAMILOther | Sell | 5.0K | ₹12.0L | 240.00 | 41.6K → 36.6K | 0.00%0.00 pp | 7(2)told 30 Aug 2023 |
| 30 Aug 2023 | VEENA VASANTHOther | Sell | 6.0K | ₹15.6L | 260.20 | 90.0K → 84.0K | 0.01%-0.00 pp | 7(2)told 30 Aug 2023 |
| 30 Aug 2023 | MANEESH H GHILDYALEmployee | Sell | 2.0K | ₹5.2L | 259.40 | 1.24L → 1.22L | 0.01%-0.00 pp | 7(2)told 29 Aug 2023 |
| 30 Aug 2023 | MANEESH H GHILDYALEmployee | Sell | 2.0K | ₹5.2L | 260.15 | 1.26L → 1.24L | 0.01%-0.00 pp | 7(2)told 29 Aug 2023 |
| 25 Aug 2023 | EPURI LAKSHMI NARAYANAOther | Sell | 9.9K | ₹25.5L | 257.58 | 10.1K → 225 | 0.00%0.00 pp | 7(2)told 23 Aug 2023 |
SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.
How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session
Bulk & block deals · 14 Jul 2026
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 14 Jul 2026 | Sell · block, also bulk | MYLAN INC. | 4.60Cr | 400.00 | ₹1,839.3Cr |
| 14 Jul 2026 | Buy · block, also bulk | ICICI PRUDENTIAL MUTUAL FUND | 1.84Cr | 400.00 | ₹737.5Cr |
| 14 Jul 2026 | Buy · block | HDFC MUTUAL FUND | 58.29L | 400.00 | ₹233.2Cr |
| 14 Jul 2026 | Buy · block | KOTAK MAHINDRA MUTUAL FUND | 58.29L | 400.00 | ₹233.2Cr |
| 14 Jul 2026 | Buy · block | SBI MUTUAL FUND | 18.75L | 400.00 | ₹75.0Cr |
| 14 Jul 2026 | Buy · block | ADITYA BIRLA SUNLIFE MUTUAL FUND | 12.50L | 400.00 | ₹50.0Cr |
| 14 Jul 2026 | Buy · block | ICICI PRUDENTIAL LIFE INSURANCECOMPANY LTD. | 12.50L | 400.00 | ₹50.0Cr |
| 14 Jul 2026 | Buy · block | FRANKLIN TEMPLETON MUTUAL FUND | 9.38L | 400.00 | ₹37.5Cr |
| 14 Jul 2026 | Buy · block | MIRAE ASSET MUTUAL FUND | 9.38L | 400.00 | ₹37.5Cr |
| 14 Jul 2026 | Buy · block | BNP PARIBAS ARBITRAGE | 7.50L | 400.00 | ₹30.0Cr |
| 14 Jul 2026 | Buy · block | CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED | 7.50L | 400.00 | ₹30.0Cr |
| 14 Jul 2026 | Buy · block | 360 ONE MUTUAL FUND | 6.26L | 400.00 | ₹25.0Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.
Exchange surveillance
- P/E > 50 (4 quarters) · since 8 Aug 2025 — P/E above 50 on the last four quarters’ earnings.
Price band: No band · not in the F&O ban · 46.7% of the market-wide position limit used.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes · ban days · MWPL.
Every stock on this session →Futures & options · 20 Nov 2026
CSVShort covering — price up as positions closed — shorts buying back.
- Futures OI
- 4.81Cr
- OI change
- -1.15%
- Basis
- -0.32%
- Rollover
- 81.0%
- PCR (OI)
- 0.83
- PCR (volume)
- 0.69
- Front settle
- 363.30
- Lot size
- 2,500
- Futures volume
- 11.9K
- Futures trades
- 9,059
- Futures value
- ₹1,085.7Cr
- Sessions shown
- 250
₹1,753.2Cr
shares
contracts
Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.
Option chain · 20 Nov 2026 · lot 2,500
Put OICall OI- Max pain
- 340
- Call OI wall
- 380
- Put OI wall
- 310
- PCR (OI, this expiry)
- 0.80
-6.7% from spot
340: puts 39.90L OI (−3.40L), close 0.15, ₹31.7Cr notional in 209 trades · calls 43.42L OI (−4.35L), close 23.20, ₹19.8Cr notional in 132 trades
Open interest in shares on the 20 Nov 2026 session, around the cash price. MP is max pain, the strike where option holders would collect least at expiry; CW and PW are the strikes above and below the price with the most open calls and puts. On expiry day the front is already the next expiry. Scan them with max_pain, call_oi_wall and put_oi_wall.
Financials · quarterly statement
| Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Q2 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 3,953.7 | 3,917.1 | 3,432.9 | 3,590.4 | 3,821.4 | 4,417.0 | 3,941.9 | 4,295.5 | 4,173.0 | 4,516.6 | 4,336.0 | 4,388.9 | |
| Other income | 565.5 | 48.6 | 1,134.5 | 32.5 | 34.8 | 36.9 | 79.7 | 93.0 | 117.3 | 52.5 | 54.5 | 34.5 | |
| Total income | 4,519.2 | 3,965.7 | 4,567.4 | 3,622.9 | 3,856.2 | 4,453.9 | 4,021.6 | 4,388.5 | 4,290.3 | 4,569.1 | 4,390.5 | 4,423.4 | |
| Total expenses | 3,708.1 | 3,635.2 | 3,453.9 | 3,550.5 | 3,718.4 | 3,987.5 | 3,924.7 | 4,205.3 | 4,064.7 | 4,241.2 | 4,249.4 | 4,361.9 | |
| └ Finance costs | 266.7 | 227.0 | 236.0 | 225.6 | 223.4 | 212.4 | 276.7 | 272.2 | 209.9 | 231.5 | 213.2 | 240.1 | |
| └ Depreciation | 414.5 | 407.0 | 405.4 | 419.9 | 425.4 | 436.3 | 455.0 | 473.0 | 515.3 | 513.4 | 547.4 | 563.8 | |
| Profit before tax | 832.3 | 321.7 | 1,145.5 | 98.4 | 155.9 | 486.8 | 96.9 | 171.3 | (67.8) | 247.5 | 127.6 | 54.8 | |
| Tax expense | 54.9 | 96.1 | 283.7 | 71.3 | 74.8 | 27.4 | 7.7 | 38.5 | (16.0) | 48.9 | (9.2) | (1.9) | |
| Net profit | 753.3 | 222.9 | 861.8 | 27.1 | 81.1 | 459.4 | 89.2 | 132.8 | (51.8) | 198.6 | 136.8 | 56.7 | |
| EPS | 5.52 | 1.13 | 5.51 | -0.13 | 0.21 | 2.88 | 0.26 | 0.66 | 1.08 | 0.79 | 0.87 | 0.25 | |
| Net margin | 19.05% | 5.69% | 25.10% | 0.75% | 2.12% | 10.40% | 2.26% | 3.09% | -1.24% | 4.40% | 3.15% | 1.29% | |
| PBT margin | 21.05% | 8.21% | 33.37% | 2.74% | 4.08% | 11.02% | 2.46% | 3.99% | -1.62% | 5.48% | 2.94% | 1.25% | |
| Tax rate | 6.60% | 29.87% | 24.77% | 72.46% | 47.98% | 5.63% | 7.95% | 22.48% | — | 19.76% | -7.21% | -3.47% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 4 Nov 2026.
Balance sheet & cash flow · half-yearly
Balance sheet
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 52,042.8 | 54,576.9 | 56,070.7 | 57,127.9 | 58,797.3 | 62,759.8 | 63,650.6 | 65,279.5 | |
| Current assets | 12,334.0 | 14,069.9 | 15,179.2 | 15,153.5 | 16,286.2 | 18,781.1 | 17,179.8 | 18,010.0 | |
| └ Cash & equivalents | 1,323.5 | 644.4 | 1,233.6 | 1,687.7 | 3,227.1 | 4,274.7 | 2,416.5 | 2,203.9 | |
| └ Other bank balances | 1,076.6 | 1,344.5 | 1,025.1 | 406.7 | 893.1 | 326.4 | 777.1 | 218.5 | |
| └ Current investments | 1,326.5 | 1,797.3 | 315.6 | 555.9 | 447.3 | 1,502.4 | 689.8 | 264.3 | |
| └ Trade receivables | 3,573.2 | 4,033.2 | 6,230.6 | 6,129.2 | 5,487.9 | 5,519.2 | 5,986.8 | 6,059.2 | |
| └ Inventories | 4,243.7 | 4,910.8 | 4,943.9 | 4,965.1 | 4,931.1 | 5,776.8 | 6,085.7 | 7,145.2 | |
| Total equity | 22,488.8 | 24,277.4 | 25,274.8 | 26,720.0 | 27,712.5 | 33,055.2 | 36,621.5 | 37,156.0 | |
| └ Attributable to owners | 17,866.9 | 18,982.4 | 19,783.7 | 20,993.2 | 21,644.0 | 26,803.6 | 34,031.8 | 34,842.8 | |
| └ Non-controlling interest | 4,621.9 | 5,295.0 | 5,491.1 | 5,726.8 | 6,068.5 | 6,251.6 | 2,589.7 | 2,313.2 | |
| └ Share capital | 600.3 | 600.3 | 600.3 | 600.3 | 600.3 | 668.5 | 810.5 | 814.8 | |
| Borrowings | 17,770.7 | 17,823.8 | 15,729.6 | 16,149.8 | 17,755.5 | 15,907.7 | 14,824.7 | 15,110.1 | |
| └ Current | 2,480.2 | 2,816.5 | 2,797.2 | 4,168.3 | 5,350.1 | 5,337.7 | 4,078.4 | 4,083.2 | |
| └ Non-current | 15,290.5 | 15,007.3 | 12,932.4 | 11,981.5 | 12,405.4 | 10,570.0 | 10,746.3 | 11,026.9 | |
| Trade payables | 3,983.1 | 4,392.5 | 6,272.0 | 6,368.9 | 6,548.7 | 6,975.6 | 6,772.1 | 7,871.3 | |
| Current liabilities | 8,510.7 | 10,366.4 | 15,358.8 | 15,805.1 | 14,333.8 | 16,254.2 | 14,069.2 | 14,730.6 | |
| Total liabilities | 29,554.0 | 30,299.5 | 30,795.9 | 30,407.9 | 31,084.8 | 29,704.6 | 27,029.1 | 28,123.5 | |
| Net debt | 14,044.1 | 14,037.6 | 13,155.3 | 13,499.5 | 13,188.0 | 9,804.2 | 10,941.3 | 12,423.4 | |
| Debt / equity | 0.79 | 0.73 | 0.62 | 0.60 | 0.64 | 0.48 | 0.40 | 0.41 | |
| Current ratio | 1.45 | 1.36 | 0.99 | 0.96 | 1.14 | 1.16 | 1.22 | 1.22 |
Cash flow, year to date
| FY23 | H1 FY24 | FY24 | H1 FY25 | FY25 | H1 FY26 | FY26 | H1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,852.5 | (377.5) | 2,953.9 | 705.4 | 4,061.2 | 803.4 | 1,994.0 | 769.0 | |
| └ Capex | (1,726.3) | (900.2) | (1,931.6) | (900.9) | (2,343.3) | (919.5) | (1,911.7) | (839.0) | |
| Free cash flow | 126.2 | (1,277.7) | 1,022.3 | (195.5) | 1,717.9 | (116.1) | 82.3 | (70.0) | |
| Investing cash flow | (14,281.8) | (994.9) | (1,004.5) | 966.2 | (234.1) | (1,275.9) | (2,082.1) | (286.0) | |
| Financing cash flow | 13,048.7 | 487.5 | (2,332.7) | (1,278.6) | (1,854.0) | 1,403.1 | (923.6) | (754.6) | |
| └ Dividends paid | (71.8) | (203.0) | (203.0) | (82.9) | (82.9) | (90.8) | (90.8) | (105.6) | |
| └ Buybacks | (64.7) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net change in cash | 641.1 | (894.8) | (380.4) | 403.1 | 2,004.3 | 930.6 | (1,011.7) | (271.6) |
From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.
Announcements & board meetings
As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.
Every stock on this session →BIOCON at a glance
- BIOCON closed at ₹364.4 on 20 Nov 2026, +0.21% on the day, -11.4% over one year, 18.5% below its 52-week high of ₹447.15.
- Delivery was 53.1% of traded quantity on 20 Nov 2026, the 92nd percentile of its own 3,629 sessions with a reading (20-session average 46.3%, 1-year average 48.8%).
- Market capitalisation is ₹59,386 crore at a trailing P/E of 131.4 (trailing EPS ₹2.77).
- Q2 FY27 results (consolidated, filed 4 Nov 2026): revenue ₹4,389 crore (+2.2% year on year), net profit ₹57 crore (-57.3%); the price moved +5.1% on the first session after.
- Promoters held 44.68% at 30 Sept 2026, unchanged on the previous filing.
- Q3 FY27 results are expected between 21 Jan 2027 and 15 Feb 2027, going by past filing dates — an estimate, not an announcement.
About
Sector history
- to 16 Aug 2026Index industry · Healthcare
- from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
NSE’s own classification, by the snapshot it changed on.
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Pharmaceuticals & Biotechnology
- DIDIVISLABDivi's Laboratories Limited11,180.50+0.02%
- LALAURUSLABSLaurus Labs Limited2,294.60-0.49%
- SUSUNPHARMASun Pharmaceutical Industries Limited1,884.90-0.79%
- ACACUTAASAcutaas Chemicals Limited3,833.50-3.61%
- SASAILIFESai Life Sciences Limited1,800.70+0.69%
- PPPPLPHARMAPiramal Pharma Limited239.30-0.15%
- DRDRREDDYDr. Reddy's Laboratories Limited1,390.20-0.76%
- GLGLENMARKGlenmark Pharmaceuticals Limited2,648.00+1.51%
- AUAUROPHARMAAurobindo Pharma Limited1,799.00-0.37%
- CICIPLACipla Limited1,415.00-0.25%
- ZYZYDUSLIFEZydus Lifesciences Limited1,200.00-0.24%
- MAMANKINDMankind Pharma Limited2,665.00+1.37%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE